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Abstract
Escherichia coli ST131 is a globally disseminated, multidrug resistant clone responsible for a high proportion of urinary tract
and bloodstream infections. The rapid emergence and successful spread of E. coli ST131 is strongly associated with
antibiotic resistance; however, this phenotype alone is unlikely to explain its dominance amongst multidrug resistant
uropathogens circulating worldwide in hospitals and the community. Thus, a greater understanding of the molecular
mechanisms that underpin the fitness of E. coli ST131 is required. In this study, we employed hyper-saturated transposon
mutagenesis in combination with multiplexed transposon directed insertion-site sequencing to define the essential genes
required for in vitro growth and the serum resistome (i.e. genes required for resistance to human serum) of E. coli EC958, a
representative of the predominant E. coli ST131 clonal lineage. We identified 315 essential genes in E. coli EC958, 231 (73%)
of which were also essential in E. coli K-12. The serum resistome comprised 56 genes, the majority of which encode
membrane proteins or factors involved in lipopolysaccharide (LPS) biosynthesis. Targeted mutagenesis confirmed a role in
serum resistance for 46 (82%) of these genes. The murein lipoprotein Lpp, along with two lipid A-core biosynthesis enzymes
WaaP and WaaG, were most strongly associated with serum resistance. While LPS was the main resistance mechanism
defined for E. coli EC958 in serum, the enterobacterial common antigen and colanic acid also impacted on this phenotype.
Our analysis also identified a novel function for two genes, hyxA and hyxR, as minor regulators of O-antigen chain length.
This study offers novel insight into the genetic make-up of E. coli ST131, and provides a framework for future research on E.
coli and other Gram-negative pathogens to define their essential gene repertoire and to dissect the molecular mechanisms
that enable them to survive in the bloodstream and cause disease.
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Introduction
Escherichia coli O25b:H4-ST131 (E. coli ST131) is a recently
emerged, globally disseminated clone that is often multidrug
resistant and is responsible for a high proportion of community-
and nosocomially-acquired urinary tract and bloodstream infec-
tions [1–6]. E. coli ST131 strains are also capable of causing
complicated infections including acute pyelonephritis, osteomye-
litis, septic arthritis and septic shock [7,8]. E. coli ST131 are
commonly associated with production of the CTX-M-15 enzyme,
currently the most widespread extended spectrum b-lactamase
(ESBL) of its type in the world [1,9]. In addition to resistance
against oxyimino-cephalosporins (i.e. cefotaxime, ceftazidime), and
monobactams, E. coli ST131 strains are often co-resistant to
fluoroquinolones [3,10]. Indeed, most fluoroquinolone-resistant E.
coli strains belong to a recently emerged and dominant subgroup of
ST131 strains [11]. Some E. coli ST131 strains have also been
reported to produce carbapenemases [12–14], thus severely
limiting treatment options that are currently available against this
clinically predominant clone [15].
E. coli ST131 strains, like many other uropathogenic E. coli
(UPEC) strains, are derived from phylogenetic group B2 [3].
Typically, UPEC strains possess a large and diverse range of
virulence factors that contribute to their ability to cause urinary
tract and bloodstream infections, including adhesins, toxins,
siderophores and protectins [15,16]. Several studies have demon-
strated that E. coli ST131 strains possess a similar suite of virulence
factors and cause invasive disease, leading to the hypothesis that
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the widespread pathogenic success of E. coli ST131 strains may be
in part due to enhanced virulence [7,8,17]. However, it has
become clear from recent studies that E. coli ST131 strains do not
possess a heightened virulence potential compared to other UPEC
or B2 E. coli strains in causing invasive infections [18] or infections
in nematodes and zebrafish embryos [19]. Thus, other factors such
as enhanced metabolic capacity have been proposed to contribute
to the fitness and pathogenic success of this dominant clone
[20,21].
The genome sequence of one of the best-characterized E. coli
ST131 strains, EC958, was recently described [22]. E. coli EC958
is a member of the pulsed-field gel electrophoresis (PFGE) defined
UK epidemic strain A, which represents one of the major
pathogenic lineages (PFGE strains A–E) of ESBL producing E. coli
causing urinary tract infections (UTI) across the UK [23]. E. coli
EC958 is resistant to eight antibiotic classes, including oxyimino-
cephalosporins, fluoroquinolones and sulphonamides. E. coli
EC958 colonizes the bladder of mice in a type 1 fimbriae-
dependent manner [22], can invade into bladder epithelial cells
and form intracellular bacterial communities, can establish both
acute and chronic UTI [24] and can inhibit the contraction of
ureters, in vitro [25].
The ability to resist the bactericidal activity of serum, and thus
survive in the bloodstream, represents an essential virulence trait
for UPEC and other extra-intestinal E. coli (ExPEC) strains,
including E. coli ST131 [26–28]. In E. coli, several mechanisms
have been shown to contribute to serum resistance. The
importance of O-antigens and K capsules in resistance to serum
has been recognized since the 1960s and 1980s, respectively [29–
31]; and their multiple types, combinations and length contribute
differently to serum resistance [32–35]. The major outer
membrane protein OmpA [36], plasmid-encoded proteins TraT
[37,38] and Iss [39], and the phage membrane protein Bor [40]
have also been reported to contribute to serum resistance in E. coli.
Notably, each of these resistance mechanisms has been studied in
isolation and in different strain backgrounds. Thus, while serum
resistance is clearly a complex phenotype determined by multiple
elements, little is known about the combination of factors that
contribute to resistance in a single strain.
High-throughput transposon mutagenesis combined with ge-
nome-wide targeted sequencing was used recently to study the
essential genes in Salmonella enterica serovar Typhi and Caulobacter
crescentus [41,42]. Langridge et al. also used their transposon
directed insertion-site sequencing (TraDIS) method to assay every
gene for its role in the survival of S. Typhi in the presence of bile
salts [42]. Similar approaches (INSeq, HITS, Tn-seq) have also
been applied to a range of organisms to study gene requirements
for survival in particular niches [43–46]. Here, we adapted
TraDIS and designed a multiplexing method to define the
essential genes required for in vitro growth (i.e. Luria-Bertani agar
media supplemented with 30 mg/ml Cm at 37uC) and the serum
resistome (i.e. genes required for resistance to human serum, in E.
coli EC958). We show that the essential gene list of E. coli EC958
comprises 315 genes, 231 of which are shared with E. coli K-12.
We also define for the first time a comprehensive inventory of
genes required for resistance to human serum. Our study provides
a molecular blueprint for understanding the mechanisms em-
ployed by E. coli ST131 to survive, grow in the bloodstream and
cause disease.
Results
Application of multiplexed TraDIS to the E. coli ST131
strain EC958
Approximately 1 million mutants were generated in the E. coli
ST131 strain EC958 [22] using an in-house miniTn5 transposon
carrying a chloramphenicol (Cm) resistance gene derived from the
pKD3 plasmid [47]. A primer comprising four functional regions
was designed to facilitate specific sequencing of the transposon
insertion sites on the Illumina HiSeq 2000 platform while allowing
for intra-lane multiple sample indexing (Figure S1). This primer
contained (59-39): (i) the P5 sequence to bind to TruSeq flowcells,
(ii) the Illumina read 1 sequencing primer binding site, (iii) a 6-bp
index sequence for multiple sample barcoding and (iv) a 25-bp
transposon specific sequence designed to amplify the last 12 bp of
the transposon and its adjacent genomic sequence. Using this
custom primer, we successfully sequenced the transposon insertion
sites for 6 samples on both TruSeq version 2 and version 3
flowcells (Figure 1A). Each sample yielded from 6.8 million to 15
million reads that were tagged with transposon specific sequence,
71% of which were reliably mapped to EC958 draft chromosome
(excluding unscaffolded contigs and plasmids) (Table 1). All
experiments were performed in duplicate, with the correlation
coefficient for the number of insertions per gene for each pair of
samples close to 1 (R2.0.99) and thus demonstrating a high level
of reproducibility for each experiment (Figure 1B).
Essential genes in E. coli EC958
We initially used our saturated random insertion mutant library
to determine the ‘essential genes of EC958’, defined as the set of
genes required for growth on LB agar supplemented with Cm
30 mg/ml. We extracted genomic DNA (in duplicates: input A and
B) directly from the library pool and sequenced using our
multiplexed TraDIS protocol. We combined the reads from input
A and B to maximize the coverage resulting in 16 million
transposon-tagged reads, of which 11 million uniquely mapped to
the EC958 chromosome, resulting in 502,068 unique insertion
sites. This equates to an average of one insertion site every
9.92 bp, with a very low probability of having 100 consecutive bp
without interruption by chance (P= 4.261025).
Author Summary
The emergence and rapid dissemination of new bacterial
pathogens presents multiple challenges to healthcare
systems, including the need for rapid detection, precise
diagnostics, effective transmission control and effective
treatment. E. coli ST131 is an example of a recently
emerged multidrug resistant pathogen that is capable of
causing urinary tract and bloodstream infections with
limited available treatment options. In order to increase
our molecular understanding of E. coli ST131, we devel-
oped a high-throughput transposon mutagenesis system
in combination with next generation sequencing to test
every gene for its essential role in growth and for its
contribution to serum resistance. We identified 315
essential genes, 270 of which were conserved among all
currently available complete E. coli genomes. Fifty-six
genes that define the serum resistome of E. coli ST131
were identified, including genes encoding membrane
proteins, proteins involved in LPS biosynthesis, regulators
and several novel proteins with previously unknown
function. This study therefore provides an inventory of
essential and serum resistance genes that could form a
framework for the future development of targeted
therapeutics to prevent disease caused by multidrug-
resistant E. coli ST131 strains.
Serum Resistome of an E. coli ST131 Strain
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The essential gene list was identified using a statistical analysis
similar to that described by Langridge et al., which recognized two
distinct distributions of insertion indexes (number of insertions
divided by gene length) for non-essential genes (gamma) and
essential genes (exponential) and called those with insertion
indexes less than or equal to the intercept of the two distributions
as essential [42]. In our data, an insertion index cut-off of 0.0158,
resulted in the identification of 315 genes as essential (Table S1).
This cut-off is equivalent to a log2-likelihood-ratio (LLR) of 23.6,
which means that our essential genes are at least 12 times more
likely to belong to the exponential distribution (essential) than the
gamma (non-essential) distribution.
The functional category of each gene was identified based on
the COG (Clusters of Orthologous Groups) numbers from the
EC958 annotation (accession number PRJEA61443). Figure 2
shows an overview of essential functions in EC958 compared with
the total number of genes in each functional category. Genes
involved in translation, ribosomal structure and biogenesis account
for 25% of the total number of essential genes in EC958, which is
42% of the total number of genes in this category. The second
most abundant category in the essential gene list comprised genes
involved in cell wall/membrane/envelope biogenesis (12%),
followed by genes involved in coenzyme transport and metabo-
lism. There were 23 essential genes with functions not identified in
the COG database.
To investigate the conservation of EC958 essential proteins
among different E. coli pathotypes, we performed tfastx alignment
(FASTA v36) between the essential protein sequences and
translated DNA from 50 E. coli complete genomes (Table S2).
There were 270 (86%) proteins conserved across all genomes
investigated. An additional 17 proteins were also present in more
than 90% of the genomes. Only 6 proteins were specific for EC958
(not found in 50 genomes) (Table S3).
The serum resistome of E. coli EC958
Saturated transposon mutagenesis in combination with next-
generation sequencing is a powerful tool for whole genome, high-
throughput identification of all candidate genes involved in a
particular phenotype. Here, we used our transposon mutant
library in combination with TraDIS to identify genes from EC958
involved in resistance to human serum, thus enabling us to define
the serum resistome of EC958. We designed a mutant selection
procedure in which 1 million mutants were exposed to pooled
fresh human serum for 90 minutes and then allowed to grow in LB
broth for 4 hours before genomic DNA extraction. This procedure
permitted the growth of serum resistant mutants while eliminating
or inhibiting mutants that were sensitive to serum (Figure 3A). The
procedure was performed in parallel with control samples where
fresh serum was replaced by inactivated serum that lacked
bactericidal activity (data not shown). The genomic DNA from
test and control samples were sequenced using our modified
Illumina multiplexed TraDIS procedure (Figure 3B) to generate
multiple datasets (Figure 1A) that were analysed by the
Bioconductor package edgeR after filtering out genes identified
as essential [48].
The serum resistance genes were identified as genes that have
significant reduction in read counts in the test samples compared
to the control samples (i.e. less mutants survived after serum
treatment) (Table S4). A stringent threshold of log2 fold change of
read counts (logFC) less than 21 and an adjusted p-value less than
Figure 1. Summary of sequence read data from multiplexed TraDIS. (A) Number of tagged reads obtained in each lane of TruSeq version 2
and version 3 flowcells. (B) Correlation between the two biological replicates. The number of insertions in each gene from Test A was plotted against
that from Test B; the correlation coefficient R2 indicates very low variation between the two replicates.
doi:10.1371/journal.pgen.1003834.g001
Table 1. Summary of sequencing and mapping results of multiplexed TraDIS runs.
Tagged reads Reads mapped to EC958 chromosome (%) Unique insertion sites in EC958
Input A & B 16,281,107 11,558,154 (70.99) 502,068
Test A 6,819,691 4,879,098 (71.54) 438,706
Test B 7,572,730 5,408,136 (71.41) 436,858
Ctrl A 8,350,687 5,918,766 (70.87) 394,521
Ctrl B 15,006,139 10,727,954 (71.49) 485,459
doi:10.1371/journal.pgen.1003834.t001
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0.001 was used to identify significant genes that are involved in
serum resistance (Figure S2). Figure 4 shows the names and
genomic locations of the 56 genes that satisfied these stringent
criteria.
Twenty-two (39.3%) of the genes belong to three operons
responsible for LPS biosynthesis (including both O-antigen
biosynthesis and lipid A-core biosynthesis) and enterobacterial
common antigen (ECA) biosynthesis. This result represents the
first layer of evidence demonstrating the importance of the O25
antigen as well as ECA in an E. coli ST131 background for
protection from the bactericidal activity of human serum.
Detailed characterisation of the O25 antigen gene cluster is
discussed in subsequent sections. ECA is common to all
Enterobacteriaceae and is expressed in both serum resistant (smooth)
and sensitive (rough) strains, except for rough strains that are
defective in the shared biosynthesis pathway affecting both O-
antigen and ECA [49,50]. Seven out of 12 genes in the ECA
operon were required for serum resistance as determined by the
TraDIS technique.
The remaining 60.7% of genes in the serum resistome identified
by TraDIS included genes encoding lipoprotein, membrane
proteins, regulators and hypothetical proteins (Table 2). Some of
these also affect LPS such as rfaH (EC958_4322), encoding a
known regulator required for LPS biosynthesis [51,52] and
virulence of pathogenic E. coli strains [53,54], whilst others
represent genes that have not previously been shown to be
associated with serum resistance. The murein lipoprotein gene lpp
(EC958_1897) showed the greatest difference between the test and
control samples (logFC of 210), followed by pgm (EC958_0806),
encoding phosphoglucomutase. Four hypothetical proteins were
also identified, two of which (EC958_0460 and EC958_0461)
were further characterized in this study (see below).
Validation of serum resistance genes
As mentioned above, we employed a stringent threshold
combining fold change and statistical significance to define the
set of 56 genes in the EC958 serum resistome. In order to validate
these findings, we attempted to test all 56 genes independently for
their role in serum resistance. Using a modified lambda red
mediated-homologous recombination approach [22,47] we suc-
cessfully generated defined knock-out mutants for 54 genes
(96.4%) in EC958. We were unable to obtain mutants for the
remaining 2 genes (acrA and EC958_2373) despite multiple
attempts (Table 2).
Figure 2. Number of essential genes in each COG functional category.
doi:10.1371/journal.pgen.1003834.g002
Serum Resistome of an E. coli ST131 Strain
PLOS Genetics | www.plosgenetics.org 4 October 2013 | Volume 9 | Issue 10 | e1003834
The 54 defined mutants were subjected to serum susceptibility
testing, whereby the number of surviving colonies after a 90-
minute exposure to fresh pooled human serum was compared to
the number of colonies prior to treatment (Table 2). A mutant was
defined as susceptible to serum when its log difference was at least
1 (i.e. 10 fold reduction after exposure to serum). Forty-one genes
(75.9%) contributed to serum resistance in EC958 using this assay.
In the case of the remaining 13 mutants, it is possible that the lack
of susceptibility to human serum was a reflection of the assay,
suggesting that survival in serum within a mixed population of one
million mutants may be very different from survival of a pure
population carrying the same defective mutation. Therefore, to
better mimic the condition of TraDIS library serum selection, a
competitive assay was devised where EC958 wild-type was mixed
equally with a mutant before exposure to serum and the
competitive index of the mutant was measured. Using this
competitive assay, five of the twelve mutants were significantly
attenuated compared to the wild-type EC958 strain (Table 2).
Thus, the overall number of validated susceptible mutants was 46
out of 54 tested (85.2%).
Additional characteristics of serum resistant mutants
We hypothesized that one mechanism associated with enhanced
sensitivity to human serum could be due to decreased membrane
integrity caused by destabilization of the outer leaflet of the outer
membrane. In order to test this, we examined the survival of the
54 mutants in response to outer membrane stresses (i.e. SDS) and
osmotic potential (i.e. NaCl). In total, 50.0% (27/54) of the
mutants displayed enhanced sensitivity to SDS and 11.1% (6/54)
of the mutants displayed enhanced sensitivity to NaCl (Table 2). A
comparative analysis of these phenotypes in the context of serum
sensitivity is presented below.
O25b antigen biosynthesis genes conferring resistance to
serum
It is well established that O-antigen represents the main
determinant for serum resistance in E. coli. However, there are
more than 180 different O-antigens that have been defined in E.
coli and these may contribute differently to serum resistance in
individual bacterial strains [32,33]. Furthermore, direct genetic
evidence linking O-antigen biosynthesis to serum resistance is only
available for a small number of specific O-antigen types. With this
in mind, a detailed characterization of the O25b biosynthesis
genes was performed using sequence comparison for function
prediction in combination with analysis of LPS composition to
deduce the role of each gene in resistance to serum.
Similar to most E. coli strains, the O-antigen biosynthesis operon
is located between the galF and gnd genes in EC958. Figure 5A
shows a comparison of the EC958 O-antigen operon with the
equivalent operon from the K-12 strain MG1655 and the O25
serotype E. coli strain E47a [32,55].
Nucleotide sugar biosynthesis genes. The four genes
encoding dTDP-a-L-rhamnose biosynthesis enzymes were highly
conserved in the three strains, consistent with the presence of a-L-
rhamnose in the O16 and O25 antigen repeat unit expressed by
MG1655 and EC958, respectively [56–58]. The dTDP-a-L-
rhamnose biosynthesis pathway starts from a-D-glucose-1-phos-
phate to produce dTDP-a-L-rhamnose via the catalysis of RmlA
(to make dTDP-a-D-glucose), RmlB (to make dTDP-4-dehydro-6-
deoxy-a-D-glucose), RmlC (to make dTDP-4-dehydro-6-deoxy-b-
mannose) and RmlD (to make dTDP-a-L-rhamnose), respectively.
LPS gel analysis of EC958 mutants lacking one of these four
enzymes showed that RmlC and RmlD were required for the
biosynthesis of O-antigen and mutation in either gene resulted in
cells with only the lipid A core (Figure 5C). On the contrary, the
Figure 3. Experimental design to identify serum resistance genes in EC958. (A) Selection steps employed using fresh serum as test and
inactivated serum as control. (B) Schematic illustration of the Illumina sequencing procedure including the use of a custom oligo for indexing and
enrichment of insert sites.
doi:10.1371/journal.pgen.1003834.g003
Serum Resistome of an E. coli ST131 Strain
PLOS Genetics | www.plosgenetics.org 5 October 2013 | Volume 9 | Issue 10 | e1003834
LPS patterns of rmlA and rmlB mutants showed only a small
change in intensity but retained most of the O-antigen chain
length distribution, except for the very long chain length band.
This might be explained by the existence of RffH and RffG, two
isozymes of RmlA and RmlB, in EC958. RffH and RffG, however,
were not able to fully compensate for RmlA or RmlB in resistance
to serum (Table 2). The inability to produce the very long chain
length O-antigen in rmlA and rmlB mutants might be a crucial
factor in determining their susceptibility to human serum. Only
the rmlC mutant displayed altered sensitivity to SDS, while
mutations in rmlABCD did not affect sensitivity to NaCl (Table 2).
The O-antigen operon in E47a has another set of nucleotide
sugar biosynthesis genes (fnlABC) for the biosynthesis of UDP-N-
acetyl-a-L-fucosamine (UDP-FucNAc) from UDP-N-acetyl-a-D-
glucosamine (UDP-GlcNAc). Curiously, EC958 does not have
these three genes in the operon or anywhere else in its genome.
O-antigen processing genes. The O-antigen flippase (Wzx,
EC958_2377) and O-antigen polymerase (Wzy, EC958_2374)
from EC958 are highly similar to the corresponding genes from
E47a. In contrast, both genes share very low similarity to the
corresponding genes from MG1655. Mutation of the wzx gene in
MG1655 results in the accumulation of high levels of the UndPP-
O unit in the cytoplasm [59] and hypersensitivity to several
antibiotics and other agents including nalidixic acid, tetracycline,
mitomycin C and hydrogen peroxide [60]. Transcriptional
analyses of MG1655 responses to the broad-spectrum biocide
polyhexamethylene biguanide suggested that Wzx (also known as
RfbX) might be involved in cellular stress responses [61]. In
contrast to the previous studies, the wzx gene was defined as
essential in this study (Figure 4, Table S1). This might be
explained by the fact that Cm was used to select for transposon
mutants and the wzx mutants might be hypersensitive to this
antibiotic. The wzy O-antigen polymerase gene (EC958_2374) was
also defined as essential in EC958 and thus was not further
characterized. Mutation of the chain length regulator gene (wzz,
EC958_2368) showed a non-modal distribution of O-antigen
chain length in its LPS pattern (Figure 5C), an observation
consistent with previous study describing the role of this gene [62].
The reduction of long chain length O-antigen in this mutant is
likely to account for the serum sensitivity shown in our assay
(Table 2).
Glycosyltransferases genes. Glycosyltransferases (GTs) are
required to form the glycosidic bonds between sugars in an O-
antigen repeat unit. There are now more than 100,000 GTs within
94 families (http://www.cazy.org). Based on the structure of the
O25 repeat unit [63,64], we predicted a requirement for 4 GTs in
EC958. Bioinformatic analysis (blastp) confirmed that there are
indeed 4 GTs within the O-antigen operon: EC958_2371,
EC958_2372, EC958_2375 and EC958_2376. Surprisingly, two
of the predicted GTs in EC958 are very different from those in
E47a. Whether this is related to the different source of a-L-
FucNAc in EC958 due to the lack of fnlABC remains to be
Figure 4. Overview of the E. coli EC958 serum resistance genes. The circular diagram depicts the location of 56 serum resistance genes on the
E. coli EC958 genome. The two outer rings containing blue and red arrows illustrate the CDS and serum resistance genes, respectively, on the forward
and reverse strand of the genome. The inner red ring represents the logFC between the control and the test samples for each CDS. The three insets
represent a close-up look at three regions on the genome with the graphs showing the location and relative number of each mutant found in the
control (blue) and test (red) samples.
doi:10.1371/journal.pgen.1003834.g004
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Table 2. Genes required for serum resistance identified by multiplexed TraDIS.
EC958
locus_tag
Gene
Name
Matched in
MG1655 Product Seruma LPSc
SDS
MICd
(%)
NaCl
MICd
(M)
COG
code
EC958_0147 dnaJ b0015 DnaJ chaperone 1 WT WT WT O
EC958_0152 nhaA b0019 Sodium/proton antiporter 0b WT WT WT P
EC958_0260 acnB b0118 aconitate hydratase 2/2-methylisocitrate dehydratase 1 WT WT WT C
EC958_0460 0460 - - 3 X WT WT -
EC958_0461 0461 - - 1b X WT WT TK
EC958_0602 acrA b0463 multidrug efflux system N/A N/A N/A N/A M
EC958_0784 nagC b0676 Transcriptional regulator, repressor of N-acetylglucosamine 1 WT WT WT KG
EC958_0785 nagA b0677 N-acetylglucosamine-6-phosphate deacetylase 3 X 0.063 WT G
EC958_0806 pgm b0688 Phosphoglucomutase 4 X 0.016 WT G
EC958_0856 tolQ b0737 membrane spanning protein in Tol-Pal cell envelope complex 3 WT 0.031 WT U
EC958_0858 tolA b0739 membrane anchored protein in Tol-Pal cell envelope complex 3 WT 0.031 WT M
EC958_0859 tolB b0740 periplasmic protein in Tol-Pal cell envelope complex 0 WT WT WT U
EC958_0871 galE b0759 UDP-galactose-4-epimerase 1 X WT WT M
EC958_1112 1112 - - 1 X WT WT -
EC958_1114 1114 - - 2 WT WT WT -
EC958_1897 lpp b1677 murein lipoprotein 6 WT 0.063 WT M
EC958_2368 wzz b2027 regulator of O-antigen chain length 1 X WT WT M
EC958_2371 2371 - - 2 LA 0.063 WT R
EC958_2373 2373 - - N/A N/A N/A N/A E
EC958_2378 rmlC b2038 dTDP-4-deoxyrhamnose-3,5-epimerase 4 LA 0.063 WT M
EC958_2379 rmlA b2039 glucose-1-phosphate thymidylyltransferase 2 X WT WT M
EC958_2380 rmlD b2040 dTDP-4-dehydrorhamnose reductase 4 LA WT WT M
EC958_2381 rmlB b2041 dTDP-glucose 4,6 dehydratase 3 X WT WT M
EC958_2390 wcaI b2050 glycosyl transferase involved in colanic acid synthesis 0b WT WT WT M
EC958_2391 gmm b2051 GDP-mannose mannosyl hydrolase 1b WT WT WT F
EC958_2394 wcaF b2054 predicted acyl transferase 4 X 0.063 0.5 R
EC958_2594 arnD b2256 undecaprenyl phosphate-alpha-L-ara4FN deformylase 2 WT 0.063 WT G
EC958_2596 arnE b4544 ArnE/ArnF undecaprenyl-phosphate-a-L-Ara4N flippase 1 WT WT WT P
EC958_2597 arnF b2258 ArnE/ArnF undecaprenyl-phosphate-a-L-Ara4N flippase 2 WT WT WT -
EC958_2652 dedA b2317 conserved inner membrane protein 1b WT WT WT S
EC958_2653 truA b2318 pseudouridylate synthase I 0b WT WT WT J
EC958_2822 bamB b2512 lipoprotein required for OM biogenesis, in BamABCD complex 3 WT 0.063 WT S
EC958_3571 nusA b3169 transcription termination/antitermination L factor 0b WT WT WT K
EC958_3581 greA b3181 transcript cleavage factor 2 WT 0.063 WT K
EC958_3621 sspA b3229 stringent starvation protein A 2 WT 0.063 WT O
EC958_4029 waaL b3622 O-antigen ligase 3 LA 0.063 WT M
EC958_4030 waaK b3623 Lipopolysaccharide core biosynthesis; heptosyl transferase IV 3 LA 0.063 WT M
EC958_4032 waaY b3625 Lipopolysaccharide core heptose (II) kinase 5 LA WT ,0.3 T
EC958_4033 waaJ b3626 UDP-glucose:(glucosyl)LPS a-1,2-glucosyltransferase 2 LA 0.063 WT M
EC958_4034 waaI b3627 UDP-D-glucose:(glucosyl)LPS a-1,3-glucosyltransferase 5 X 0.063 0.5 M
EC958_4035 waaB b3628 UDP-D-galactose:(glucosyl)LPS-1, 6-D-galactosyltransferase 4 X WT WT M
EC958_4037 waaP b3630 Lipopolysaccharide core heptose (I) kinase 6 X 0.016 WT -
EC958_4038 waaG b3631 Lipopolysaccharide glucosyltransferase I 6 X 0.016 0.5 M
EC958_4050 pyrE b3642 orotate phosphoribosyltransferase 2 WT WT WT F
EC958_4246 wecA b3784 undecaprenyl-phosphate a-N-acetylglucosaminyl transferase 5 LA 0.063 WT M
EC958_4247 wzzE b3785 ECA polysaccharide chain length modulation protein 2 X 0.063 WT M
EC958_4252 wecD b3790 TDP-fucosamine acetyltransferase 5 X 0.063 WT -
EC958_4253 wecE b3791 TDP-4-oxo-6-deoxy-D-glucose transaminase 2 WT WT WT M
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investigated. Since the O25 antigen structure is known, we
attempted to predict the glycosidic link formed by each GT using a
combination of sequence similarity and O-antigen structure
comparison as previously described [64]; the results of which are
shown in Table 3 and Figure 5B. We were only able to mutate
EC958_2371, while EC958_2372 and EC958_2375 were defined
as essential in this study. Analysis of our EC958_2371 mutant
confirmed that EC958_2371 is required for O-antigen biosynthe-
sis (Figure 5C), serum resistance and resistance to SDS (Table 2).
Other serum resistance mechanisms affecting LPS in
EC958
LPS gel analysis was performed on all 54 defined mutants to
identify genes that contribute to serum resistance by affecting LPS
(Figure S3). The normal LPS pattern of EC958 consists of 12
bands including a thick bottom band representing the lipid A-core
and an 11-band laddering pattern of lipid A-core bound O-antigen
polymers, followed by approximately 6 thick bands of very long O-
antigen chain length (Figure 5C). In addition to the 6 genes
involved in O-antigen biosynthesis mentioned above, the LPS
patterns of 20 mutants were altered in comparison to wild-type
EC958; 6 of these mutants (waaLKYJ, wecA and rfaH) only
produced a lipid A-core (Table 2 and Figure S3).
LPS core biosynthesis genes. The genes involved in
biosynthesis of the LPS outer core in EC958 share strong
similarity with those from K-12 MG1655 (waaL and waaGPBIJYK)
[reviewed in 65,66], suggesting that the LPS outer core structure
in EC958 is the same as that in MG1655. As expected from the
functions of waaGBIJK in MG1655, the waaG mutant showed the
smallest size of lipid A-core, indicating that its whole outer core
was not linked to the lipid A-inner core. Mutations in waaIJYK also
produced an expected LPS pattern of lipid A-core only, as these
mutations prevent the linkage of O-antigen to the outer core. The
LPS of the waaB and waaP mutants produced O-antigen laddering
patterns containing an abnormal lipidA-core band, indicating that
although the core structures were changed, these changes still
allow the linking of O-antigen to the outer core. WaaL is
responsible for the ligation of O-antigen to the outer core and
mutation of this gene resulted in the synthesis of a lipid A-core
without O-antigen. The EC958 waaL and waaGPBIJYK mutants
were sensitive to human serum and SDS (except for the waaB and
waaY mutant), while only the waaG, waaI and waaY mutants
displayed enhanced sensitivity to NaCl (Table 2).
ECA biosynthesis genes. Seven serum resistant candidate
genes within the ECA biosynthesis wec operon were identified by
TraDIS (Table 2). Two of these genes (wzxE and wzyE) were not
confirmed by serum assays to confer resistance and no changes
were observed in the LPS patterns of these two mutants (Table 2,
Figure S3). The wzyE mutant (but not the wzxE mutant) was,
however, more sensitive to SDS (Table 2). The LPS patterns of the
wzzE mutant revealed changes in the lipid A-core and in the
modulation of O-antigen chain length (Figure S3). WzxE has
previously been shown to preferentially form a protein complex
with WzyE and WzzE for the biosynthesis of ECA over Wzy and
Wzz [67]. However, our results suggested that WzzE might also
contribute to the chain length regulation of O-antigen in EC958.
WecA has been shown previously to be involved in the
biosynthesis of O7, O18, O75, and O111 antigen [68] and our
results indicate that the same is also true for O25b, thus explaining
the role of WecA in serum resistance in EC958. The wecD mutant
was highly sensitive to serum, possessed an LPS profile that was
altered in both the lipid A-core and the amount of O-antigen, and
displayed enhanced sensitivity to SDS (Table 2, Figure S3).
Further investigation is required to understand the involvement of
WecD in lipid A-core and O-antigen biosynthesis. Finally, none of
the ECA biosynthesis mutants were altered in sensitivity to NaCl.
Other genes. The remaining 8 mutants with altered LPS
patterns were all confirmed as serum sensitive (Table 2). They
included one mutant, rfaH, which produced only lipid A-core, and
7 mutants with different O-antigen patterns: hyxA (EC958_0460),
hyxR (EC958_0461), nagA (N-acetylglucosamine-6-phosphate dea-
cetylase), pgm (phosphoglucomutase), galE (UDP-galactose-4-epim-
erase), EC958_1112 and wcaF (predicted acetyltransferase in-
volved in colanic acid synthesis [69]). Some of these genes were
also associated with resistance to additional stresses; EC958 rfaH
and wcaF mutants were sensitive to SDS and NaCl, while nagA and
pgm mutants were sensitive to SDS (Table 2).
Novel O-antigen chain length regulators
Mutation of the hyxA and hyxR genes in EC958 resulted in the
modulation of O-antigen chain length (Figure 6B). The EC958
Table 2. Cont.
EC958
locus_tag
Gene
Name
Matched in
MG1655 Product Seruma LPSc
SDS
MICd
(%)
NaCl
MICd
(M)
COG
code
EC958_4254 wzxE b3792 lipid III flippase 0b WT WT WT R
EC958_4255 wecF b4481 TDP-Fuc4NAc:lipidIIFuc4NAc transferase 1b WT 0.063 WT -
EC958_4256 wzyE b3793 ECA polysaccharide chain elongation 0b WT 0.063 WT -
EC958_4322 rfaH b3842 DNA-binding transcriptional antiterminator 5 LA 0.016 ,0.3 K
EC958_4336 dsbA b3860 Protein disulfide oxidoreductase 1 WT 0.031 0.6 O
EC958_4480 pgi b4025 glucosephosphate isomerase 1b WT 0.063 WT G
EC958_4658 miaA b4171 D(2)-isopentenylpyrophosphate tRNA-adenosine transferase 0b WT 0.063 WT J
EC958_4725 fbp b4232 fructose-1,6-bisphosphatase I 3 WT WT WT G
aSerum sensitivity was shown as 2log10 of viable count difference between t = 90 min and t = 0 min. The higher the number the more sensitive the mutant is.
bSerum sensitivity was determined by competitive assays: 0 means no difference was found between the wild-type and mutant; 1 means the mutant was more
attenuated than the wild-type.
cLPS patterns were coded as followed: WT, similar to wild-type strain, no change observed; LA, only the band for lipid A-core observed; LA+1, lipid A-core band and only
one band above it; X, changes observed, see Supplementary Figure S3 for band patterns.
dThe wild-type (WT) MIC is 0.8 M for NaCl and 0.125% for SDS.
doi:10.1371/journal.pgen.1003834.t002
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hyxA mutant exhibited an increased proportion of O-antigen chain
of 2 to 6 units with maximum number at 3–5 units and reduction
in very high chain length polymer. The EC958 hyxR mutant had
an increased proportion of O-antigen polymer of 2–4 units. The
hyxA and hyxR genes are located in a pathogenicity island (PAI-X)
consisting of 4 genes (fimX and hyxRAB) as previously described in
the UPEC strain UTI89 [70]. The hyxB gene (EC958_0459) has
also been named upaB due to its function as an autotransporter
[71], and we prefer to maintain this nomenclature. This island is
present (in several variations) in 24 out of 50 E. coli genomes across
all pathotypes (Figure 6A) and current sequence data suggest that
it is exclusive to E. coli.
No functional prediction was found for hyxA, and thus this is
the first report of hyxA involvement in serum resistance by
regulating O-antigen chain length. The hyxR gene encodes a
LuxR-like response regulator that suppresses the nitrosative stress
response and contributes to intracellular survival in macrophages
by regulating hmpA, which encodes a nitric oxide-detoxifying
flavohaemoglobin [70]. The expression of the hyxR gene is
regulated through bidirectional phase inversion of its promoter
region by the upstream gene fimX, which encodes a tyrosine-like
recombinase [70]. It is also worth noting that the contribution of
hyxA to serum resistance was greater than hyxR, as demonstrated
by the 3-log reduction in viability by the hyxA mutant compared
to the hyxR mutant. A serum sensitive phenotype for the hyxR
mutant was only observed in mixed competition assays, and both
mutants did not exhibit altered sensitivity to SDS or NaCl
(Table 2).
Novel serum resistance mechanisms not affecting LPS
A major advantage of whole genome approaches such as
TraDIS lies in their power of discovery. Out of 46 genes that
define the serum resistome of EC958, 21 (46%) genes were
confirmed to be required for serum resistance independent of
altered LPS patterns (Table 2; Figure S3). The function of these
genes ranged across 10 COG functional categories and included
‘Carbohydrate transport and metabolism’ (4 genes), ‘Cell wall/
membrane/envelope biogenesis’ (3), ‘Posttranslational modifica-
tion, protein turnover, chaperones’ (3) and many others (Table 2).
Twelve of these genes were also associated with enhanced
sensitivity to SDS and one with enhanced NaCl sensitivity
(Table 2)
Of the non-LPS genes required for serum resistance, the most
notable was lpp (logFC 210, log difference = 6) (Table 2). The lpp
gene encodes one of the most abundant proteins in E. coli and is
responsible for the stabilisation and integrity of the bacterial cell
envelope [72]. Mutation of the lpp gene results in the formation of
outer membrane blebs, leakage of periplasmic enzyme ribonucle-
ase, decreased growth rate in media of low ionic strength or low
osmolarity and hypersensitive to toxic compounds [73,74]. Indeed,
the EC958 lpp mutant was more sensitive to SDS, suggesting
decreased membrane integrity (Table 2). To the best of our
knowledge, this study is the first to show a direct link between Lpp
and serum resistance.
Another set of genes notable in our TraDIS analysis include
tolQAB, which encode three of the six proteins (YbgC-YbgF-TolQ-
R-A-B-Pal) that make up the Tol-Pal system of E. coli cell
Figure 5. Characterization of O25b antigen genes in EC958. (A) Comparison of the O-antigen cluster in EC958 with MG1655 (NC_000913) and
E47a (GU014554); genes in green are involved in sugar biosynthesis, genes in purple are involved in O-antigen processing and genes in orange
encode glycosyl transferase enzymes; genes with a black outline were shown to be required for serum resistance and genes with a red outline were
defined as essential. (B) Predicted function of the four glycosyl transferases in the biosynthesis of the O25b repeat unit [57,58]. (C) LPS gels showing
changes in O-antigen structures corresponding to mutations in each gene.
doi:10.1371/journal.pgen.1003834.g005
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envelope. The Tol-Pal system is responsible for maintaining the
integrity of the outer membrane. TolQRA form an inner
membrane complex in which TolQR is necessary for its stability
[75]. TolB, a periplasmic protein, connects the inner membrane
complex with the peptidoglycan-associated lipoprotein, Pal, which
is anchored to the outer membrane [76]. In our study, mutation of
the tolA and tolQ genes caused sensitivity to human serum and
increased sensitivity to SDS, while the tolB mutant did not
(Table 2). Our results demonstrate that the Tol-Pal system is
important for resistance to human serum, and thus describe a
novel function for this important cell wall complex.
BamB is a lipoprotein that is part of the BamABCD complex.
Mutation in bamB results in increased outer membrane perme-
ability, thus enhancing sensitivity to rifampin and dramatically
reducing growth on SDS and novobiocin [77]. Our data showed
that mutation of the bamB gene in EC958 resulted in increased
sensitivity to both human serum and SDS (Table 2).
Our TraDIS experiment also indicated that the modification of
lipid A with L-Ara4N was important for serum resistance. Three
(arnDEF) of the seven genes involved in the biosynthesis and
attachment of L-Ara4N to lipid A-core were identified as part of
the serum resistome of EC958 and their role was confirmed by
mutagenesis (Table 2). This mechanism is known to confer
resistance to polymixin B by preventing its binding to lipid A
[Reviewed in 78,79,80]. ArnD catalyzes a deformylation step to
generate UDP-L-Ara4N before it is transported across the inner
membrane by ArnEF [79,81]. The requirement of ArnDEF for
serum resistance indicates that EC958 requires L-Ara4N modifi-
cation to evade the antimicrobial activity of cationic peptides
present in human serum. Interestingly, only the arnD mutation
conferred sensitivity to SDS (Table 2), which might suggest a role
of UDP-L-Ara4N in maintaining membrane integrity. Further
investigation is needed to understand why ArnT, the final enzyme
required for transferring the L-Ara4N residue to the 49-phosphate
group of lipid A-core, was not identified in our TraDIS-defined
serum resistome.
We also identified three genes encoding catabolic enzymes that
contributed to the serum resistance phenotype of EC958 (gmm, pgi
and fbp) and confirmed their role by mutagenesis (Table 2). Of these
genes, only the pgi mutant displayed enhanced sensitivity to SDS
(Table 2). Gmm is a GDP-mannose mannosyl hydrolase capable of
hydrolyzing both GDP-mannose and GDP-glucose [82]. This
enzyme contributes to the biosynthesis of GDP-fucose, a compo-
nent of colanic acid, possibly by influencing the concentration of
Table 3. Summary of E. coli EC958 O25b antigen biosynthesis genes.
Locus tag Gene
No. of
amino
acids Similar protein
% identities/%
positives/no. of
amino acid
overlap predicted function
EC958_2381 rmlB 361 dTDP-glucose 4,6-dehydratase [Escherichia coli NA114]
(YP_006139244)
99/100/361 dTDP-glucose 4,6-dehydratase
EC958_2380 rmlD 299 dTDP-4-dehydrorhamnose reductase [Escherichia
coli NA114] (YP_006139241)
100/100/299 dTDP-4-dehydrorhamnose reductase
EC958_2379 rmlA 292 glucose-1-phosphate thymidylyltransferase
[Escherichia coli NA114] (YP_006139242)
100/100/292 glucose-1-phosphate thymidylyltransferase
EC958_2378 rmlC 180 dTDP-4-dehydrorhamnose 3,5-epimerase
[Escherichia coli NA114] (YP_006139241)
99/99/180 dTDP-4-dehydrorhamnose 3,5-epimerase
EC958_2377 wzx 419 O-antigen flippase Wzx [Escherichia coli E47a]
(ADI43260)
95/98/149 O-antigen flippase
EC958_2376 wekA 321 putative glycosyl transferase family 2
[Escherichia coli ABU83972] (ADN46883)
93/98/321 glycosyl transferase family 2;
a-L-FucpNAc-(1-.3)-b-D-GlcpNAc
EC958_2375 wekB 382 putative glycosyl transferase [Escherichia coli E47a]
(ADI43262)
93/97/382 glycosyl transferase family 4;
b-D-Glcp-(1-.6)- a-D-Glcp
glycosyl transferase WcmS [Escherichia
coli E1020-72, O158] (ADN43874)
39/59/372
EC958_2374 wzy 405 O-antigen polymerase Wzy [Escherichia coli E47a]
(ADI43263)
92/95/346 O-antigen polymerase
EC958_2373 wbbJ 201 predicted lipopolysaccharide biosynthesis
O-acetyl transferase [Escherichia coli str. K-12
substr. MG1655] (NP_416537)
68/80/194 predicted lipopolysaccharide
biosynthesis O-acetyl transferase
EC958_2372 wbuH 366 Putative glycosyltransferase WbuH
[Escherichia coli O4:K3:H5] (AAT85654)
29/49/372 glycosyl transferase family 4;
a-D-Glcp-(1-.3)- a-L-FucpNAc
EC958_2371 wbbL 263 Rhamnosyltransferase [Escherichia coli str. K-12
substr. MG1655] (P36667)
60/76/260 glycosyl transferase family 2;
Rhamnosyltransferase:a-L-Rhap(1-.3)a-D-Glcp
EC958_2370 gnd 468 6-phosphogluconate dehydrogenase
[Escherichia coli NA114] (YP_006137974.1)
100/100/468 6-phosphogluconate dehydrogenase
EC958_2369 ugd 388 UDP-glucose-6-dehydrogenase [Escherichia coli NA114]
(YP_006137975)
100/100/388 UDP-glucose-6-dehydrogenase
EC958_2368 wzz 325 regulator of length of O-antigen component of
lipopolysaccharide chain [Escherichia coli NA114]
(YP_006137976)
100/100/325 O-antigen chain length regulator
doi:10.1371/journal.pgen.1003834.t003
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GDP-mannose or GDP-glucose in the cell and thus regulating cell
wall biosynthesis [82]. Both Pgi and Fbp catalyze the production of
D-fructose-6-phosphate from b-D-glucose-6-phosphate and fruc-
tose-1,6-bisphosphate, respectively [83,84]. D-fructose-6-phosphate
is a precursor for the biosynthesis of UDP-GlcNAc, which in turn is
required for peptidoglycan, lipid A and ECA biosynthesis. Thus,
these three enzymes may catalyse key reactions that, if disrupted,
could adversely affect the downstream biosynthesis of cell surface
components including colanic acid, peptidoglycan, lipid A and
ECA.
An ompA mutant is protected from serum killing when
present at a low proportion in a mixed bacterial
population
Of all the chromosomal genes previously attributed to serum
resistance, the only gene that was not identified in our TraDIS
screen was ompA. To examine this further we constructed an
EC958 ompA mutant and indeed observed it was sensitive to killing
by human serum (Figure 7). One way to explain this discrepancy is
that the phenotype of an ompA mutant could be complemented in
trans by other ompA-intact bacteria in a mixed population such as
the mutant library. In fact, OmpA inhibits serum-mediated killing
by binding to C4b-binding protein (C4BP) to prevent the
activation of C3b via the classical complement pathway [85],
and OmpA is known to be released from E. coli cells when treated
with serum [86]. In our mutant library, ompA mutants only
accounted for approximately 0.02% of the total bacterial cells, and
thus we hypothesized that the release of OmpA from 99.98% of
the cells, when treated with serum, provided OmpA in trans to
complement ompA mutants. We tested this hypothesis by mixing
the ompA mutant with wild-type EC958 at various ratios and
indeed showed that ompA mutants were protected from serum
killing if the proportion of ompA mutants was less than 15%
(Figure 7). This result strongly suggests that in trans complemen-
tation of OmpA prevents the identification of ompA as a serum
resistance gene in our assay.
Complementation of selected mutants restores serum
resistance
To further demonstrate the function of non-LPS genes in serum
resistance, we selected three orphan genes (acnB, greA and fbp) that
do not belong to an operon to perform genetic complementation.
Figure 6. Genetic context of the hyxA and hyxR genes and their role in O-antigen synthesis. (A) The conserved location of PAI-X containing
hyxAR genes in E. coli genomes of various pathotypes. (B) The LPS pattern of the hyxA and hyxR mutants and their complemented strains,
demonstrating a role for the hyxA and hyxR genes in O-antigen chain length regulation. Red boxes highlight differences in LPS patterns compared
with that of the wild-type.
doi:10.1371/journal.pgen.1003834.g006
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For these experiments, the selected gene was amplified by PCR,
cloned into the low copy number plasmid pSU2718G, and
transformed into the respective mutant strain for complementa-
tion. In each case, the phenotype of the complemented strain
exactly matched that of wild-type EC958 (Table 4). Taken
together, these results confirm the role of acnB, greA and fbp in
serum resistance and provide a further layer of evidence to support
the use of techniques such as TraDIS in functional gene discovery.
Discussion
The rapid advancement of new sequencing technologies has
created novel opportunities to interrogate biological systems that
were not previously possible. TraDIS was first described as a
method that combined high-density mutagenesis with Illumina
next generation sequencing technology to study the essential genes
of S. Typhi and the conditional essential genes required for
survival in bile [42]. The increased data output afforded by next
generation DNA sequencing is particularly useful and cost-
effective for small bacterial genomes, however it presents technical
and bioinformatical challenges for applications such as TraDIS
that utilize low complexity DNA libraries. Here we present the
application of a modified version of TraDIS that is amenable to
multiplexing using the Illumina HiSeq 2000 platform, and we
demonstrate its effectiveness by using it to define the essential gene
repertoire and the serum resistome of a multidrug resistant strain
from the globally disseminated E. coli ST131 lineage.
The multiplexed TraDIS protocol utilizes a newly designed
custom oligonucleotide in the library enrichment step of the
Illumina library preparation protocol (Figure S1). This oligonu-
cleotide incorporates the Illumina sequencing primer-binding site
into transposon specific DNA fragments, enabling the use of the
standard Illumina sequencing primer and eliminating the need to
design and optimize another sequencing primer for each new
transposon sequence. The 6-bp barcode immediately after the
sequencing primer-binding site allows 12-sample multiplexing
within one lane. The use of 12 barcodes at the first 6 nucleotides of
read 1 increased the complexity of the library compared with the
original TraDIS protocol, thus reducing data loss due to mis-
identification of clusters [87,88]. However, the number of useable
reads from our sequencing runs was still low (15–20% of total
reads). We believe non-specific amplification in the enrichment
step was the main cause, and further optimization of the
enrichment PCR conditions is required. Similar approaches
combining transposon mutagenesis with high-throughput sequenc-
ing (Tn-seq [45], INSeq [43], HITS [44]) have also been used to
address different scientific questions, including the identification of
essential genes and genes associated with enhanced fitness in
specific growth conditions [41,42,45], determination of niche-
specific essential genes [43,44,89], identification of genes associ-
ated with tolerance to various agents/conditions [42,90] and many
other applications as reviewed elsewhere [91,92]. In terms of
insertion density, we achieved 502,068 independent insertion sites
with a density of 1/10 bp (i.e. one insertion every 10 bp), which is
comparable with the work by Christen et al. (1/8 bp in C. crescentus)
[41], Langridge et al. (1/13 bp in Salmonella Typhi) [42] and
Barquist et al. (1/9 bp in Salmonella Typhimurium) [46].
The identification of the essential gene set for a single organism
is challenging due to several factors, including the presence of
transposon insertion cold spots (i.e. regions of low transposon
insertion frequency), the difficulty in distinguishing mutations that
prevent growth from those that severely reduce growth rate, pre-
existing gene duplications and the specific growth conditions used
in the experiment [93–95]. In this study, we define essential genes
as those genes that, when mutated by transposon insertion, either
prevent or severely attenuate growth on LB agar media
supplemented with 30 mg/ml Cm at 37uC. The cut-off value to
determine whether a gene is essential was defined as the intercept
of two distributions of the insertion index of each gene: the
exponential distribution representing essential genes and the
gamma distribution representing non-essential genes [42]. This
means that our essential genes also include those genes that can
tolerate insertions but were severely attenuated in the input pool.
Out of 315 essential genes, 64 genes had no transposon insertions,
178 genes had 1 to 5 transposon insertions and 73 genes had more
than 5 transposon insertions (Table S1).
The high density of insertion sites achieved in our study
provided reliable data for the identification of essential genes
within the EC958 genomes with a minimal probability of false
positive calls due to transposon insertion cold spots. The
identification of essential genes has previously been performed
using several approaches in E. coli K-12 (strains MG1655 and
W3110) [96,97]. Baba et al. generated null mutations by lambda-
red recombination in 3985 E. coli W3110 genes (the Keio library),
but were unable to mutate 303 candidate essential genes [97]. This
set of essential genes was further consolidated by manual literature
review on the EcoGene website (www.ecogene.org), which
reduced the set to 289 genes. Of the 315 essential genes identified
for EC958 in this study, 231 genes (73%) matched those previously
described in the EcoGene list (Table S1). There were 84 essential
genes specific for EC958, twenty-four of which do not have
homologs in the MG1655 genome. In contrast, 58 genes
previously identified as essential for E. coli K-12 were either not
present in EC958 or not identified in our analysis. The majority of
essential genes in EC958 are conserved with 91% of the genes
present in more than 90% of E. coli complete genomes available.
In this study, we provided two layers of evidence for the role of
each serum resistance gene: by simultaneously assaying a large
mutant library and by generation of defined mutants for
independent phenotypic testing. Indeed, using defined mutagen-
esis we were able to confirm a role for 46 of the 56 genes identified
Figure 7. In trans complementation of wild-type EC958 protects
ompA mutants from serum killing. Wild-type EC958 and an EC958
ompA mutant were mixed at different ratios, exposed to human serum
for 90 minutes, and the EC958 ompA mutant was examined for its
sensitivity to human serum (expressed as the 2log10 CFU difference
between time 90 and time 0). The red line indicates the threshold below
which a strain was considered resistant to serum killing. The EC958
ompA mutant was protected from killing when present at a percentage
of 15% or less in the mixed bacterial suspension.
doi:10.1371/journal.pgen.1003834.g007
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by TraDIS in serum resistance. To the best of our knowledge, this
represents the first large scale follow-up of TraDIS data in this
manner and highlights the effectiveness of the technique in large-
scale functional genomics. Our study also revealed that trans
complementation of specific mutants can occur in a large mutant
library population, as demonstrated by our findings with an ompA
mutant. We also demonstrated complete complementation of
mutants containing deletions in the acnB, greA and fbp genes,
corroborating their novel role in serum resistance independent of
LPS alterations. Finally, we provided further insight into the
mechanistic action of the serum resistance genes identified in
EC958 by examining the survival of the respective mutants to
outer membrane stresses that affect antimicrobial access and
osmotic potential.
The search for genetic determinants of serum resistance in
bacteria has been ongoing since the 1970s [98]. Our current
understanding of the mechanisms that promote bacterial resis-
tance to human serum include a role for surface structures such as
O antigens, K antigens, outer membrane proteins (OmpA), and
plasmid-encoded proteins (TraT, Iss) [37–39]; notably, however,
not all of these mechanisms are required for resistance in a single
bacterial strain [32,33]. Our study represents the first report to
simultaneously investigate the entire serum resistome of one strain.
Our results demonstrated that both the lipid A-core and O25
antigen are crucial for serum resistance in EC958, while K antigen
does not contribute to serum resistance. Out of 54 defined mutants
investigated, half had changes in their LPS gel patterns, all of
which resulted in serum sensitivity. In contrast, none of the K
capsular biosynthesis genes were identified in our TraDIS screen.
This result is similar to that reported for the O75:K5 UPEC strain
GR-12, where alterations in O75 LPS affected serum resistance
more than a K5 null mutation [34]. It is likely, however, that there
are strain-specific differences for the role of O antigen and K
capsule in serum resistance, and that this reflects differences in the
make-up of these structures. For example, previous analysis of an
E. coli O4:K54:H5 blood isolate revealed that the K54 antigen
contributes more to serum resistance than the O4 antigen [99].
Other K antigens such as the K1 and K2 capsules have also been
shown to play an important role in serum resistance [100,101].
The K antigen expressed by EC958 has not been typed but
genomic analysis shows that EC958 has a group 2 capsular gene
cluster that conforms to the conserved structure of this group
[Reviewed in 102]. However, region 2, which encodes glycosyl-
transferases specific for each K type, shares such low similarity
with available sequences in the GenBank database that deducing
its K type in silico was not possible.
The O25 antigen gene cluster was further characterized using
sequence analysis, targeted mutation and LPS profiling. All of the
dTDP-a-L-rhamnose biosynthesis genes (rmlCADB) were required
for serum resistance. However, EC958 lacks the biosynthesis genes
for UDP-FucNAc, a component of O25 antigen unit. If, based on
the cross reaction of antiserum against the O25 antigen with O25b
expressing cells, we assume that EC958 has the same O-antigen
repeat unit as the O25 determined from previous studies [57,58],
then EC958 must possess a novel mechanism for the synthesis or
uptake of UDP-FucNAc.
Two additional surface antigens that contribute to serum
resistance in EC958 are the enterobacterial common antigen and
colanic acid (M antigen). Mutations in five ECA biosynthesis genes
rendered EC958 susceptible to serum. While mutation of three of
these genes (wecA, wzzE and wecD) affected LPS and sensitivity to
SDS, mutation of wecE and wecF did not change LPS (although a
wecF mutant was more sensitive to SDS), suggesting that the ECA
may be involved in serum resistance, perhaps indirectly via its role
in membrane integrity. Our data also suggest the involvement of
colanic acid in serum resistance. Three genes encoding for colanic
acid biosynthesis (wcaI, gmm and wcaF) were identified by TraDIS.
Gmm is most likely to be involved in the biosynthesis of colanic
acid [82], while mutation of the wcaI gene did not confer serum
resistance. The product of wcaF was predicted to be an
acetyltransferase [103] required for colanic acid production [69].
The EC958 wcaF mutant possessed an altered LPS pattern with a
reduced amount of O-antigen (especially very long chain length
O-antigen) and was sensitive to both SDS and high osmolarity.
The enhanced sensitivity of the EC958 wcaF mutant could
therefore be explained by a number of factors, including altered
LPS, altered colonic acid and reduced overall membrane integrity.
A number of other genes were identified that contributed to
serum resistance in an LPS-dependent manner. The gene nagA
encodes N-acetylglucosamine-6-phosphate deacetylase, an enzyme
important for the metabolism of N-acetyl-D-glucosamine [104]. It
catalyzes the first step in producing UDP-GlcNAc, a nucleotide
sugar required for ECA, lipid A and peptidoglycan biosynthesis,
by deacetylating N-acetylglucosamine-6-phosphate to glucos-
amine-6-phosphate [Reviewed in 105]. However, NagA is not
solely responsible for the production of UDP-GlcNAc because
glucosamine-6-phosphate can also be obtained via GlmS from
fructose-6-phosphate or taken up from the environment by
ManXYZ [105]. Indeed, the LPS banding pattern of the nagA
mutant was different to that of the parent strain (i.e. it possessed
thicker second and third bands from the bottom of the gel; Figure
S3), suggesting its enhanced sensitivity phenotype may be
associated with a predominantly shorter O antigen.
Pgm is a phosphoglucomutase that catalyses the reversible
conversion of glucose-1-phosphate to glucose-6-phosphate, an
important step in galactose and maltose catabolism [106]. A pgm
mutant has several phenotypes; it is defective in swimming and
swarming mobility [107], it possesses an aberrant (shorter and
wider) cell morphology, is sensitive to detergents [108] and it stains
blue with iodine when grown in the presence of galactose [106].
An EC958 pgm mutant produced little full length O-antigen; the
majority of its LPS condensed into a thick band of incomplete lipid
A-core and a thin clear band of lipid A-core plus one unit of O-
antigen. This feature is consistent with the high serum and SDS
sensitivity phenotypes observed for this mutant.
GalE is a well-studied enzyme that catalyzes the interconversion
of UDP-galactose and UDP-glucose [Reviewed in 109]. Both
nucleotide sugars are required for colanic acid biosynthesis.
Table 4. Complementation of selected mutants.
Strains Phenotype
Seruma SDS (%)b NaCl (M)b
EC958 (wild-type) 0 0.125 0.8
EC958DacnB 1 0.125 0.8
EC958DacnB + pAcnB 0 0.125 0.8
EC958DgreA 2 0.063 0.8
EC958DgreA + pGreA 0 0.125 0.8
EC958Dfbp 3 0.125 0.8
EC958Dfbp + pFbp 0 0.125 0.8
aSerum sensitivity was shown as 2log10 of viable count difference between
t = 90 min and t = 0 min. The higher the number the more sensitive the mutant
is.
bMinimal inhibitory concentration (MIC) of SDS (%) and NaCl (M).
doi:10.1371/journal.pgen.1003834.t004
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Furthermore, UDP-glucose is used in three steps to synthesize the
LPS outer core (catalyzes by WaaG, WaaI and WaaJ). LPS
patterns of the galE mutant exhibited a very thick band of lipid A-
core, suggesting that the lipid A-core in this strain has multiple
sizes. This may be explained by the limiting effect of UDP-glucose
in the three steps involved in its incorporation into the outer core.
UDP-glucose can also be synthesized by GalU from glucose-1-
phosphate [110], which may explain why an EC958 galE mutant
could still make LPS (Figure S3). Despite being able to make LPS,
however, the galE mutant was sensitive to human serum. Whether
this sensitivity can be attributed to the effect a galE mutation has
on LPS or colanic acid remains to be determined.
We have demonstrated the successful application of multiplexed
TraDIS for a functional genomics study targeted at E. coli EC958,
a prototype strain from the globally disseminated and multidrug
resistant E. coli ST131 lineage. This approach enabled the first
description of an essential gene set from an ExPEC strain. Our
work has also defined the serum resistome in E. coli EC958. This
comprehensive inventory of E. coli EC958 genes that contribute to
this phenotype provides a framework for the future characteriza-
tion of virulence genes in ExPEC as well as other Gram-negative
pathogens that cause systemic infection.
Materials and Methods
Ethics statement
Approval for the collection of human blood was obtained from
the University of Queensland Medical Research Ethics Committee
(2008001123). All subjects provided written informed consent.
Bacterial strains and growth conditions
E. coli EC958 was isolated from the urine of a patient presenting
with community UTI in the Northwest region of England and is a
representative member of the UK epidemic strain A (PFGE type),
one of the major pathogenic lineages causing UTI across the
United Kingdom [23]. EC958Dlac, which contained a mutation in
the lac operon, was used in competitive assays. This strain had an
identical growth rate to wild-type EC958. Strains were routinely
cultured at 37uC on solid or in liquid Luria Broth (LB) medium
supplemented with the appropriate antibiotics (Cm 30 mg/ml or
gentamicin 20 mg/ml) unless indicated otherwise.
Generation of miniTn5-Cm mutant library
A miniTn5-Cm transposon containing a Cm cassette flanked by
Tn5 mosaic ends (sequence from Epicenter) was PCR amplified
from pKD3 plasmid DNA (NotI digested) using primers 2279 59-
CTGTCTCTTATACACATCTcacgtcttgagcgattgtgtagg-39 and
2280 59- CTGTCTCTTATACACATCTgacatgggaattagc-
catggtcc-39. The PCR reactions were performed using Phusion
High-Fidelity DNA polymerase (New England BioLabs). The
amplicon was purified using the QIAGEN MinElute PCR
purification kit before being phosphorylated using T4 polynucle-
otide kinase (New England BioLabs) and subjected to the final
purification step. A total of at least 800 ng of this miniTn5-Cm
transposon DNA was incubated in an 8 ml reaction containing 4 ml
of EZ-Tn5 transposase (Epicenter Biotechnologies) at 37uC for 1 h
then stored at 220uC.
Bacterial cells were prepared for electroporation as previously
described [42]. Briefly, cells were grown in 26TY broth to an
OD600 of 0.3–0.5, then harvested and washed three times in 0.56
volume of 10% cold glycerol before being resuspended in a 1/
10006volume of 10% cold glycerol and kept on ice. A volume of
60 ml cells was mixed with 0.2 ml of transposomes and electropo-
rated in a 2 mm cuvette using a BioRad GenePulser set to 2.5 kV,
25 mF and 200V. Cells were resuspended in 1 mL SOC medium
and incubated at 37uC for 2 hours, then spread on LB agar plates
supplemented with Cm 30 mg/mL. After incubation overnight at
37uC, the total number of colonies was estimated by counting a
proportion from multiple plates. Chloramphenicol resistant
colonies were resuspended in sterilised LB broth using a
bacteriological spreader before adding sterile glycerol to 15%
total volume and stored in 280uC. Each batch of mutants
contained an estimated 32,000 to 180,000 mutants. The final
library of 1 million mutants was created by pooling 11 mutant
batches, resulting in a cell suspension of 261011 CFU/ml.
Transposon library screening in human serum
Freshly pooled human serum was collected from at least two
healthy individuals on the day of the experiment. Ten milliliters of
blood was collected from each person and centrifuged at
4000 rpm for 10 minutes to collect the serum. Approximately
26108 viable mutants were incubated in 1 ml of 50% freshly
pooled human serum in LB broth at 37uC for 90 minutes. The
control samples were prepared the same way but were incubated
with inactivated serum (Millipore) instead of fresh serum. Both
control and test experiments were performed in duplicate. The
cells were then washed twice with sterile 16PBS to remove serum,
transferred to 100 ml LB broth and allowed to grow at 37uC with
250 rpm shaking for 4 hours. The genomic DNA was then
extracted from 5 ml of each culture using Qiagen 100-G genomic
tips.
Multiplexed TraDIS
Genomic DNA was standardized to 3.6 mg in a volume of
120 ml before being sheared by Covaris S2 according to the
Illumina TruSeq Enrichment gel-free method (TruSeq DNA
sample preparation v2 guide). The subsequent steps of DNA end
repair, DNA end adenylation and adapter ligation were also done
following the Illumina TruSeq v2 instructions. The adapter-ligated
fragments containing transposon insertion sites were enriched
using a transposon-specific indexing forward primer and the
Illumina reverse primer Index 1 (Table S5) at 500 nM each per
reaction. This 89 bp forward primer binds specifically to miniTn5-
Cm transposon (25 bp) and carries 64 bp overhang which includes
6 bp index sequence, 33 bp binding site for Illumina read 1
sequencing primer and 23 bp P5 sequence for binding to the
flowcell. The enrichment step was done using the KAPA Library
Amplification kit (KAPA Biosystems) at an annealing temperature
of 60uC for 22 cycles. The KAPA Library Quantification kit was
used to measure the concentration of DNA fragments in the
enriched library. Twelve libraries from 12 samples were pooled to
equimolar concentrations to achieve a cluster density of 850 K/
mm2 when 10 nM of library pool was loaded onto the flowcell.
The 12-plex pool was loaded on 3 lanes of TruSeq v2 and 3 lanes
of TruSeq v3 flowcells for sequencing using a 100 cycles, paired-
end protocol to access the reproducibility and read quantity
among lanes and flowcells. The data from six samples (Figure 1A)
were presented in this study. The TraDIS sequence data from this
study was deposited on the Sequence Read Archive (SRA) under
the BioProject number PRJNA189704.
Analysis of nucleotide sequence data
Sequence reads from the FASTQ files were split according to
twelve 6 bp index sequences combined with the 37 bp transposon-
specific sequence using fastx_barcode_splitter.pl (total length of
43 bp as barcodes, allowing for 2 mismatches) (FASTX-Toolkit
version 0.0.13, http://hannonlab.cshl.edu/fastx_toolkit/index.
html). The barcode matching reads were trimmed off the 43 bp
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barcode at the 59end and 25 bp of potential low quality at the 39
end, resulting in high quality sequence reads of 31 bp in length
that were used to map to the EC958 chromosome (PRJEA61443)
by Maq version 0.7.1 [111]. Subsequent analysis steps were
carried out as previously described [42] to calculate the number of
sequence reads (raw read counts) and the number of different
insertion sites for every gene, which were then used to estimate the
threshold to identify essential genes. The read counts and insertion
sites were visualized using Artemis version 13.0 [112]. The circular
genome diagram was generated by CGView [113] and linear
genetic comparison was illustrated using Easyfig version 2.1 [114].
Statistical analyses
We identified genes required for survival in human serum by
comparing the differences in read abundance of each gene
between the inactivated serum control and active serum test
samples using the Bioconductor package edgeR (version 2.6.10)
[48]. The raw read counts from two biological replicates of each
treatment were loaded into the edgeR package (version 2.6.12)
using the R environment (version 2.15.1). Genes that have very
low read counts in all the samples (essential genes) were removed
from further analysis. The composition bias in each sequence
library was normalized using the trimmed mean of M value
(TMM) method [115]. We then used the quantile-adjusted
conditional maximum likelihood (qCML) for negative binomial
models to estimate the dispersions (biological variation between
replicates) and to carry out the exact tests for determining genes
with significantly lower read counts in the test samples compared
to the control samples [116,117]. Stringent criteria of log fold-
change (logFC) #21 and false discovery rate #0.001 were chosen
to define a list of the most significant genes for further investigation
by phenotypic assays.
Molecular methods
Chromosomal DNA purification, PCR and DNA sequencing of
PCR products was performed as previously described [118].
Defined mutations were made using the l-Red recombinase
method with some modifications [22,47]. In brief, the final PCR
products were fused and amplified from three fragments contain-
ing two 500-bp homologous regions flanking the gene of interest
and a Cm cassette from pKD3 plasmid (see Table S5 for list of
primers). The fused PCR products were then electroporated into
EC958 harbouring a gentamicin resistant plasmid carrying the l-
Red recombinase gene. Mutants were then selected and confirmed
by sequencing. Complementation was done by cloning the gene of
interest into a gentamicin resistant derivative of pSU2718 [119] at
BamHI-XbaI cut sites (primers listed in Table S5). The construct
was then transformed into the respective mutant and induced
using 1 mM IPTG before and during phenotypic assays.
Serum resistance assay
Overnight bacterial cultures were washed in phosphate buffered
saline (PBS) and then standardized to an OD600 of 0.8. Equal
volumes (50 mL) of standardized cultures and pooled human sera
were mixed and incubated for 90 min at 37uC (in triplicates).
Viable counts were performed to estimate the number of bacterial
cells prior to serum treatment (t = 0 min) and post serum
treatment (t = 90 min). E. coli MG1655 was used as a control as
it is completely killed by serum. Serum and PBS only samples
served as sterility controls. Competitive serum resistance assays
were performed in the same manner, except that a 50:50 mixture
of wild-type (EC958Dlac) and mutant strains were used. Viable
counts were performed on MacConkey agar, which allowed the
differentiation of EC958Dlac (non-lactose fermenter) and the
mutant strains.
SDS and NaCl sensitivity assays (MIC)
The MICs of SDS and NaCl were determined by broth
microdilution method as previously described [120]. We used five
concentrations for SDS including 0.125%, 0.0625%, 0.031%,
0.016% and 0.008% in LB. For NaCl, the range of concentration
was 0.8 M, 0.6 M, 0.5 M, 0.4 M and 0.3 M.
LPS gel assay
LPS was extracted from bacterial strains and LPS patterns were
determined by Tricine-SDS Polyacrylamide gel electrophoresis
(TSDS-PAGE) and visualized by silver staining as previously
described [121,122].
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